Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism.

Kontak AC, Wang Z, Arbique D, Adams-Huet B, Auchus RJ, Nesbitt SD, Victor RG, Vongpatanasin W.

J Clin Endocrinol Metab. 2010 Oct;95(10):4756-61. doi: 10.1210/jc.2010-0823. Epub 2010 Jul 21.

2.

Normal sympathetic vasomotor and cardiac parasympathetic activities in patients with primary aldosteronism: assessment by spectral analysis.

Munakata M, Imai Y, Hashimoto J, Omata K, Nakao M, Yamamoto M, Abe K.

J Auton Nerv Syst. 1995 Apr 8;52(2-3):213-23.

PMID:
7615899
3.

Ambulatory Blood Pressure Monitoring-Derived Short-Term Blood Pressure Variability in Primary Aldosteronism.

Grillo A, Bernardi S, Rebellato A, Fabris B, Bardelli M, Burrello J, Rabbia F, Veglio F, Fallo F, Carretta R.

J Clin Hypertens (Greenwich). 2015 Aug;17(8):603-8. doi: 10.1111/jch.12551. Epub 2015 Apr 16.

4.

Does infusion of ANG II increase muscle sympathetic nerve activity in patients with primary aldosteronism?

Matsukawa T, Miyamoto T.

Am J Physiol Regul Integr Comp Physiol. 2008 Jun;294(6):R1873-9. doi: 10.1152/ajpregu.00471.2007. Epub 2008 Mar 26.

5.

Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.

Médeau V, Moreau F, Trinquart L, Clemessy M, Wémeau JL, Vantyghem MC, Plouin PF, Reznik Y.

Clin Endocrinol (Oxf). 2008 Jul;69(1):20-8. doi: 10.1111/j.1365-2265.2008.03213.x. Epub 2008 Jul 1.

PMID:
18284637
6.

The sympathetic nervous system and hypertension in primary aldosteronism.

Bravo EL, Tarazi RC, Dustan HP, Fouad FM.

Hypertension. 1985 Jan-Feb;7(1):90-6.

7.

Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy.

Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD.

Circulation. 2003 Aug 5;108(5):560-5. Epub 2003 Jul 7.

8.

Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.

Lin YH, Lin LY, Chen A, Wu XM, Lee JK, Su TC, Wu VC, Chueh SC, Lin WC, Lo MT, Wang PC, Ho YL, Wu KD; TAIPAI Study Group.

Atherosclerosis. 2012 Mar;221(1):154-9. doi: 10.1016/j.atherosclerosis.2011.12.003. Epub 2011 Dec 8.

PMID:
22197109
9.

Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism.

Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shionoiri H, Tochikubo O, Ishii M.

Hypertension. 1991 Jun;17(6 Pt 2):1057-62.

10.
11.

The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.

Somlóová Z, Widimský J Jr, Rosa J, Wichterle D, Strauch B, Petrák O, Zelinka T, Vlková J, Masek M, Dvoráková J, Holaj R.

J Hum Hypertens. 2010 Oct;24(10):625-30. doi: 10.1038/jhh.2010.65. Epub 2010 Jun 24.

PMID:
20574447
12.

Decreased blood pressure variability at rest in patients with primary aldosteronism.

Munakata M, Aihara A, Imai Y, Abe K, Yoshinaga K.

Am J Hypertens. 1998 Jul;11(7):828-38.

PMID:
9683044
13.

[Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].

Song AL, Zeng ZP, Tong AL, Lu L, Chen S, Li M, Fu CL, Wang YH, Sun ML.

Zhonghua Nei Ke Za Zhi. 2012 Apr;51(4):294-8. Chinese.

PMID:
22781950
14.

[Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].

Szücs N, Gláz E, Varga I, Tóth M, Kiss R, Patócs A, Jakab C, Perner F, Járay J, Horányi J, Dabasi G, Molnár F, Major L, Füto L, Rácz K, Tulassay Z.

Orv Hetil. 2006 Jan 15;147(2):51-9. Hungarian.

PMID:
16509213
15.

Preeclampsia -- a state of sympathetic overactivity.

Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE.

N Engl J Med. 1996 Nov 14;335(20):1480-5.

16.

Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.

Pilz S, Kienreich K, Drechsler C, Ritz E, Fahrleitner-Pammer A, Gaksch M, Meinitzer A, März W, Pieber TR, Tomaschitz A.

J Clin Endocrinol Metab. 2012 Jan;97(1):E75-9. doi: 10.1210/jc.2011-2183. Epub 2011 Oct 19.

PMID:
22013107
17.

Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism: the Cross-sectional Primary Aldosteronism and Heart Italian Multicenter Study.

Napoli C, Di Gregorio F, Leccese M, Abete P, Ambrosio G, Giusti R, Casini A, Ferrara N, De Matteis C, Sibilio G, Donzelli R, Montemarano A, Mazzeo C, Rengo F, Mansi L, Liguori A.

J Investig Med. 1999 May;47(5):212-21.

PMID:
10361380
18.
19.

Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.

TAIPAI Study Group, Wu VC, Chueh SC, Chang HW, Lin LY, Liu KL, Lin YH, Ho YL, Lin WC, Wang SM, Huang KH, Hung KY, Kao TW, Lin SL, Yen RF, Chen YM, Hsieh BS, Wu KD.

Am J Kidney Dis. 2009 Oct;54(4):665-73. doi: 10.1053/j.ajkd.2009.06.014. Epub 2009 Jul 23.

PMID:
19628318
20.

Withdrawal of endogenous sympathetic drive lowers blood pressure in primary aldosteronism.

Nicholls MG, Julius S, Zweifler AJ.

Clin Endocrinol (Oxf). 1981 Sep;15(3):253-8.

Supplemental Content

Support Center